Luteolin inhibits Nrf2 leading to negative regulation of the Nrf2/ARE pathway and sensitization of human lung carcinoma A549 cells to therapeutic drugs.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Free Radical Biology & Medicine

• Publication date

  2011-06-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.freeradbiomed.2011.03.008PMID 21402146
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Nrf2-Keap1-ARE Signaling Pathway: The Regulation and Dual Function of Nrf2 in Cancer

  2010cited by this paper
• Kaempferol Suppresses Cisplatin-Induced Apoptosis Via Inductions of Heme Oxygenase-1 and Glutamate-Cysteine Ligase Catalytic Subunit in HEI-OC1 cells

  2010cited by this paper
• Loss of Kelch-Like ECH-Associated Protein 1 Function in Prostate Cancer Cells Causes Chemoresistance and Radioresistance and Promotes Tumor Growth

  2010cited by this paper
• Neurotrophic and cytoprotective action of luteolin in PC12 cells through ERK-dependent induction of Nrf2-driven HO-1 expression.

  2010cited by this paper
• Activation of the NRF2 signaling pathway by copper-mediated redox cycling of para- and ortho-hydroquinones.

  2010cited by this paper
• Discovery of the Negative Regulator of Nrf2, Keap1: A Historical Overview

  2010cited by this paper
• Distribution and biological activities of the flavonoid luteolin.

  2009cited by this paper
• Multidrug-resistant protein-3 gene regulation by the transcription factor Nrf2 in human bronchial epithelial and non-small-cell lung carcinoma.

  2009cited by this paper
• NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer.

  2009cited by this paper
• Nrf2 Enhances Cell Proliferation and Resistance to Anticancer Drugs in Human Lung Cancer

  2009influential reference
• Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancer.

  2008cited by this paper
• Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy

  2008cited by this paper
• Loss of Keap1 function activates Nrf2 and provides advantages for lung cancer cell growth.

  2008cited by this paper
• RNAi-mediated silencing of nuclear factor erythroid-2-related factor 2 gene expression in non-small cell lung cancer inhibits tumor growth and increases efficacy of chemotherapy.

  2008cited by this paper
• Luteolin sensitizes the anticancer effect of cisplatin via c-Jun NH2-terminal kinase–mediated p53 phosphorylation and stabilization

  2007cited by this paper
• Dietary polyphenols: good, bad, or indifferent for your health?

  2007cited by this paper
• Action of Nrf2 and Keap1 in ARE-mediated NQO1 expression by quercetin.

  2007cited by this paper
• Chemopreventive promise of targeting the Nrf2 pathway.

  2007cited by this paper
• Luteolin protects rat PC12 and C6 cells against MPP+ induced toxicity via an ERK dependent Keap1-Nrf2-ARE pathway.

  2007cited by this paper
• Identification of retinoic acid as an inhibitor of transcription factor Nrf2 through activation of retinoic acid receptor alpha

  2007cited by this paper
• Plant polyphenols: How to translate their in vitro antioxidant actions to in vivo conditions

  2007cited by this paper
• Dysfunctional KEAP1–NRF2 Interaction in Non-Small-Cell Lung Cancer

  2006cited by this paper
• Structural basis for defects of Keap1 activity provoked by its point mutations in lung cancer.

  2006cited by this paper
• Role of Nrf2 in the regulation of the Mrp2 (ABCC2) gene.

  2006cited by this paper
• Dimerization of Substrate Adaptors Can Facilitate Cullin-mediated Ubiquitylation of Proteins by a “Tethering” Mechanism

  2006cited by this paper
• Mechanistic Studies of the Nrf2-Keap1 Signaling Pathway

  2006cited by this paper
• Generation of a stable antioxidant response element-driven reporter gene cell line and its use to show redox-dependent activation of nrf2 by cancer chemotherapeutic agents.

  2006influential reference
• Flavonoids protect human retinal pigment epithelial cells from oxidative-stress-induced death.

  2006cited by this paper
• Constitutive Overexpression of Nrf2-dependent Heme Oxygenase-1 in A549 Cells Contributes to Resistance to Apoptosis Induced by Epigallocatechin 3-Gallate*

  2006cited by this paper
• Mechanism of action of sulforaphane: inhibition of p38 mitogen-activated protein kinase isoforms contributing to the induction of antioxidant response element-mediated heme oxygenase-1 in human hepatoma HepG2 cells.

  2006cited by this paper
• Pro-oxidant activity of flavonoids induces EpRE-mediated gene expression.

  2006cited by this paper
• Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense.

  2005cited by this paper
• The antitumor activities of flavonoids.

  2005cited by this paper
• Relationship between hepatic phenotype and changes in gene expression in cytochrome P450 reductase (POR) null mice.

  2005cited by this paper
• Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies.

  2005cited by this paper
• Molecular mechanisms of drug resistance

  2005cited by this paper
• Bach1 Competes with Nrf2 Leading to Negative Regulation of the Antioxidant Response Element (ARE)-mediated NAD(P)H:Quinone Oxidoreductase 1 Gene Expression and Induction in Response to Antioxidants*

  2005cited by this paper
• Utility of siRNA against Keap1 as a strategy to stimulate a cancer chemopreventive phenotype.

  2005cited by this paper
• Retinoids: potential in cancer prevention and therapy

  2004cited by this paper
• Nrf2 signaling in coordinated activation of antioxidant gene expression.

  2004cited by this paper
• Ascorbic acid restores sensitivity to imatinib via suppression of Nrf2-dependent gene expression in the imatinib-resistant cell line.

  2004cited by this paper
• Transcription factor Nrf2 is required for the constitutive and inducible expression of multidrug resistance-associated protein 1 in mouse embryo fibroblasts.

  2003cited by this paper
• The role of glutathione-S-transferase in anti-cancer drug resistance

  2003cited by this paper
• Flavonoid intake and risk of chronic diseases.

  2002cited by this paper
• Dietary flavonoids: bioavailability, metabolic effects, and safety.

  2002cited by this paper
• Phytochemicals from cruciferous plants protect against cancer by modulating carcinogen metabolism.

  2001cited by this paper
• TCDD suppression of tissue transglutaminase stimulation by retinoids in malignant human keratinocytes.

  2000cited by this paper
• Dietary flavone is a potent apoptosis inducer in human colon carcinoma cells.

  2000cited by this paper
• Major differences exist in the function and tissue-specific expression of human aflatoxin B1 aldehyde reductase and the principal human aldo-keto reductase AKR1 family members.

  1999cited by this paper
• Intestinal absorption of luteolin and luteolin 7‐O‐β‐glucoside in rats and humans

  1998cited by this paper
• Computerized quantitation of synergism and antagonism of taxol, topotecan, and cisplatin against human teratocarcinoma cell growth: a rational approach to clinical protocol design.

  1994cited by this paper
• Glutathione-associated enzymes in anticancer drug resistance.

  1994cited by this paper
• Molecular mechanisms of drug resistance.

  1990cited by this paper
• Transcriptional regulation of the rat glutathione S-transferase Ya subunit gene. Characterization of a xenobiotic-responsive element controlling inducible expression by phenolic antioxidants.

  1990cited by this paper
• The role of glutathione in determining the response of normal and tumor cells to anticancer drugs.

  1987cited by this paper
• On the mechanisms of induction of cancer-protective enzymes: a unifying proposal.

  1985cited by this paper

• Design, synthesis and antiproliferative activity evaluation of new 3,7-disubstituted pyrrolo[2,3-c]pyridines

  2026cites this paper
• Anthocyanin-Rich Dark Sweet Cherry Phenolics Drive Context-Dependent Modulation of the Nrf2–Keap1–p62 Pathway in Drug-Resistant Triple Negative Breast Cancer Cells: An In Vitro Study

  2026cites this paper
• NRF2: Master regulator of cellular homeostasis and therapeutic vulnerability in cancer

  2026cites this paper
• Electroacupuncture Attenuates Ischemic White Matter Injury by Activating the Nrf2/HO-1 Axis and Suppressing Reactive Astrocyte Overactivation

  2026cites this paper
• Design and Synthesis of KRASG12C Inhibitors for Antitumor Evaluation Harboring Combination Therapy with Nrf2, PARP-7, and Pan-USP Inhibitors to Alleviate Drug Resistance Synergistically.

  2026cites this paper
• Prophylactic Olive Leaf Tea as a Nutraceutical Strategy: Tumor Suppression and Systemic Protection

  2025cites this paper
• The crosstalk between Nrf2 and pyroptosis in diseases.

  2025cites this paper
• The Nrf2 Inhibitor Brusatol Promotes Human Osteosarcoma (MG63) Growth and Blocks EB1089-Induced Differentiation

  2025cites this paper
• Thirty years of NRF2: advances and therapeutic challenges

  2025cites this paper
• Luteolin Induces Nrf2 Activity in C2C12 Cells: Implications for Muscle Health

  2025cites this paper
• Molecular Targets of Oxidative Stress: Focus on Nuclear Factor Erythroid 2–Related Factor 2 Function in Leukemia and Other Cancers

  2025cites this paper
• Pharmacological targeting of nuclear factor (erythroid-derived 2)-like 2 (NRF2): a potential strategy to improve the efficacy of oncological photodynamic therapy.

  2025cites this paper
• NRF2 activation in cancer and overview of NRF2 small molecule inhibitors

  2025cites this paper
• Potential of Apigenin, Berberine, Chrysin, and Luteolin to Overcome Doxorubicin Resistance in Acute Promyelocytic Leukemia HL-60 Cells

  2025cites this paper
• Targeting Nrf2 in acute myeloid leukemia: an updated review on its role in chemoresistance and emerging therapeutic strategies

  2025cites this paper
• Nobiletin suppresses nasopharyngeal carcinoma by regulating the KEAP1/NRF2/ARE pathway

  2025cites this paper
• Timosaponin AIII inhibits gastric cancer by causing oxidative stress and blocking autophagic flux

  2025cites this paper
• Antimycobacterial activity of luteolin in resistant Mycobacterium tuberculosis isolates and cytotoxicity on L929 cells.

  2025cites this paper
• Proteostasis Decline and Redox Imbalance in Age-Related Diseases: The Therapeutic Potential of NRF2

  2025cites this paper
• Coleus aromaticus Benth.—A Plant with Strong Anticancer and Antioxidant Potential In Vitro

  2025cites this paper
• Tart Cherry (Prunus cerasus) Extract Exerts High Intracellular ROS Scavenging Activity and Repression of ARE (Antioxidant Response Element) Pathway in Human Hepatocytes

  2025influential citation
• Integrative review of flavonoid phytosomes and their potential role in the treatment of SARS-CoV-2 infection (COVID-19), diabetes, and cancer

  2025cites this paper
• Luteolin Induces GPX4-dependent Ferroptosis and Enhances Immune Activation in Colon Cancer.

  2025cites this paper
• Cisplatin-based Liposomal Nanocarriers for Drug Delivery in Lung Cancer Therapy: Recent Progress and Future Outlooks.

  2024cites this paper
• Nrf2-Mediated Antioxidant Response and Drug Efflux Transporters Upregulation as Possible Mechanisms of Resistance in Photodynamic Therapy of Cancers

  2024cites this paper
• Luteolin affects apoptosis, migration and inflammation of lung cancer cells through regulating Keap1/Nrf2 signaling pathway

  2024cites this paper
• Mitigation of gestational diabetes-induced endothelial dysfunction through FGF21-NRF2 pathway activation involving L-Cystine.

  2024cites this paper
• NRF2 inhibitors: Recent progress, future design and therapeutic potential.

  2024cites this paper
• SN‐38, an active metabolite of irinotecan, inhibits transcription of nuclear factor erythroid 2‐related factor 2 and enhances drug sensitivity of colorectal cancer cells

  2024cites this paper
• Nrf2 Pathway and Oxidative Stress as a Common Target for Treatment of Diabetes and Its Comorbidities

  2024cites this paper
• Opposing Interplay between Nuclear Factor Erythroid 2-Related Factor 2 and Forkhead BoxO 1/3 is Responsible for Sepantronium Bromide's Poor Efficacy and Resistance in Cancer cells: Opportunity for Combination Therapy in Triple Negative Breast Cancer.

  2024cites this paper
• Role of oxidative stress‐induced ferroptosis in cancer therapy

  2024cites this paper
• Phytosomes: a critical tool for delivery of herbal drugs for cancer

  2024cites this paper
• A Comprehensive Review of Various Therapeutic Strategies for the Management of Skin Cancer

  2024cites this paper
• The inhibitory impact of Schisandrin on inflammation and oxidative stress alleviates LPS‐induced acute kidney injury

  2024cites this paper
• Luteolin as a potential therapeutic candidate for lung cancer: Emerging preclinical evidence.

  2024cites this paper
• ACA-28, an ERK MAPK Signaling Modulator, Exerts Anticancer Activity through ROS Induction in Melanoma and Pancreatic Cancer Cells

  2024cites this paper
• Medicinal plants as a potential resource for the discovery of novel structures towards cancer drug resistance treatment

  2024influential citation
• Unveiling the potential of medicinal herbs as the source for in vitro screening toward the inhibition of Nrf2

  2024influential citation
• Dysfunction of Nrf2-regulated cellular defence system and JNK activation induced by high dose of fly Ash particles are associated with pulmonary injury in mouse lungs.

  2024cites this paper
• Brusatol increases chemotherapeutic drug efficacy in pancreatic ductal adenocarcinoma by suppressing Nrf2 signaling

  2024cites this paper
• Dissecting the pleiotropic roles of reactive oxygen species (ROS) in lung cancer: From carcinogenesis toward therapy

  2024cites this paper
• Network pharmacology study to explore the multiple molecular mechanism of SH003 in the treatment of non-small cell lung cancer

  2024cites this paper
• Inhibition of NRF2 signaling overcomes acquired resistance to arsenic trioxide in FLT3-mutated Acute Myeloid Leukemia

  2024cites this paper
• Advances in Nrf2 Signaling Pathway by Targeted Nanostructured-Based Drug Delivery Systems

  2024cites this paper
• Chelerythrine induces apoptosis and ferroptosis through Nrf2 in ovarian cancer cells.

  2024cites this paper
• NRF2 Signaling Pathway in Chemo/Radio/Immuno-Therapy Resistance of Lung Cancer: Looking Beyond the Tip of the Iceberg.

  2024cites this paper
• Decrease in GPSM2 mediated by the natural product luteolin contributes to colon adenocarcinoma treatment and increases the sensitivity to fluorouracil.

  2024cites this paper
• Flavonoids as modulators of miRNA expression in pancreatic cancer: Pathways, Mechanisms, And Therapeutic Potential.

  2024cites this paper
• Protective Effects of Luteolin on a Rat Model of Autism: An Analysis of Luteolin Flavonoid’s Effects on Rat Behaviour, Histology and Cerebellar Pathology

  2024cites this paper
• Natural compounds targeting cellular redox homeostasis in malignancies.

  2023cites this paper
• The Emerging Role of Flavonoids in Autism Spectrum Disorder: A Systematic Review

  2023cites this paper
• Advances in the Role of Nrf2 in the Development of Breast Cancer and the Development of Drug Resistance

  2023cites this paper
• Dihydroartemisinin Increases the Sensitivity of Acute Myeloid Leukemia Cells to Cytarabine via the Nrf2/HO-1 Anti-Oxidant Signaling Pathway

  2023cites this paper
• Efficacy and tolerability of sulforaphane in the therapeutic management of cancers: a systematic review of randomized controlled trials

  2023cites this paper
• Alantolactone triggers oxeiptosis in human ovarian cancer cells via Nrf2 signaling pathway

  2023cites this paper
• Luteolin exhibits synergistic therapeutic efficacy with erastin to induce ferroptosis in colon cancer cells through the HIC1-mediated inhibition of GPX4 expression.

  2023cites this paper
• Phytosomes: A promising delivery system for anticancer agents by using phytochemicals in cancer therapy.

  2023influential citation
• JFD, a Novel Natural Inhibitor of Keap1 Alkylation, Suppresses Intracellular Mycobacterium Tuberculosis Growth through Keap1/Nrf2/SOD2-Mediated ROS Accumulation

  2023cites this paper
• Modulation of NRF2: Biological Dualism in Cancer, Targets and Possible Therapeutic Applications

  2023cites this paper
• Fisetin induces apoptosis in colorectal cancer cells by suppressing autophagy and down‐regulating nuclear factor erythroid 2‐related factor 2 (Nrf2)

  2023cites this paper
• Caffeic Acid Phenethyl Ester (CAPE) Synergistically Enhances Paclitaxel Activity in Ovarian Cancer Cells

  2023cites this paper
• Alkaloids as Natural NRF2 Inhibitors: Chemoprevention and Cytotoxic Action in Cancer

  2023cites this paper
• The roles of TPL in hematological malignancies

  2023cites this paper
• NRF2 has a splicing regulatory function involving the survival of motor neuron (SMN) in non-small cell lung cancer

  2023cites this paper
• Natural Nrf2 Inhibitors: A Review of Their Potential for Cancer Treatment

  2023cites this paper
• Phenolic compounds as Nrf2 inhibitors: potential applications in cancer therapy

  2023cites this paper
• MORC4 plays a tumor-promoting role in colorectal cancer via regulating PCGF1/CDKN1A axis in vitro and in vivo

  2023cites this paper
• Targeted Tumor Killing by Pomegranate Polyphenols: Pro-oxidant Role of a Classical Antioxidant.

  2023cites this paper
• Camptothecin improves sorafenib sensitivity by inhibiting Nrf2‑ARE pathway in hepatocellular carcinoma

  2023cites this paper
• Potential Mechanisms of Perillae folium Against COVID-19: A Network Pharmacology Approach

  2023cites this paper
• Modulation of Nrf2/HO-1 by Natural Compounds in Lung Cancer

  2023influential citation
• The mechanistic insights of the antioxidant Keap1-Nrf2 pathway in oncogenesis: a deadly scenario

  2023cites this paper
• Astrocyte-oligodendrocyte interaction regulates central nervous system regeneration

  2023cites this paper
• Nrf2--a Hidden Bridge Linking Cancer Stem Cells to Ferroptosis.

  2023cites this paper
• Battles against aberrant KEAP1-NRF2 signaling in lung cancer: intertwined metabolic and immune networks

  2023cites this paper
• Cancer Protective Role of Selected Dietary Polyphenols via Modulating Keap1/Nrf2/ARE and Interconnected Signaling Pathways

  2023cites this paper
• Metabolic targeting, immunotherapy and radiation in locally advanced non-small cell lung cancer: Where do we go from here?

  2022cites this paper
• Elaiophylin Inhibits Tumorigenesis of Human Lung Adenocarcinoma by Inhibiting Mitophagy via Suppression of SIRT1/Nrf2 Signaling

  2022cites this paper
• Role of STAT3 and NRF2 in Tumors: Potential Targets for Antitumor Therapy

  2022cites this paper
• Functional foods, hormesis, and oxidative stress

  2022cites this paper
• Rerouting the drug response: Overcoming metabolic adaptation in KRAS-mutant cancers

  2022cites this paper
• NRF2信号通路促进非小细胞肺癌增殖的研究进展

  2022cites this paper
• NRF2: KEAPing Tumors Protected.

  2022cites this paper
• Down-regulating Nrf2 by tangeretin reverses multiple drug resistance to both chemotherapy and EGFR tyrosine kinase inhibitors in lung cancer.

  2022cites this paper
• Development of P62-Keap1 Protein-Protein Interaction Inhibitors as Doxorubicin-Sensitizers Against Non-Small Cell Lung Cancer

  2022cites this paper
• Dual role of Nrf2 in cancer: molecular mechanisms, cellular functions and therapeutic interventions

  2022cites this paper
• The current status and future prospects for therapeutic targeting of KEAP1-NRF2 and β-TrCP-NRF2 interactions in cancer chemoresistance.

  2022cites this paper
• Metabolic targeting of NRF2 potentiates the efficacy of the TRAP1 inhibitor G-TPP through reduction of ROS detoxification in colorectal cancer.

  2022cites this paper
• Significance of NRF2 in physiological and pathological conditions an comprehensive review.

  2022cites this paper
• Advancements in clinical translation of flavonoid nanoparticles for cancer treatment

  2022cites this paper
• The therapeutic activities of metformin: Focus on the Nrf2 signaling pathway and oxidative stress amelioration.

  2022cites this paper
• Pull the plug: Anti‐angiogenesis potential of natural products in gastrointestinal cancer therapy

  2022cites this paper
• Advances in Immunosuppressive Agents Based on Signal Pathway

  2022cites this paper
• The Role and Mechanisms of Action of Natural Compounds in the Prevention and Treatment of Cancer and Cancer Metastasis.

  2022influential citation
• Screening the components of Saussurea involucrata for novel targets for the treatment of NSCLC using network pharmacology

  2022cites this paper
• Targeting NLRP3 Inflammasome With Nrf2 Inducers in Central Nervous System Disorders

  2022cites this paper
• Luteolin Reduces Aqueous Extract PM2.5-induced Metastatic Activity in H460 Lung Cancer Cells

  2022cites this paper
• Role of Nrf2 Signaling Cascade in Breast Cancer: Strategies and Treatment

  2022cites this paper
• Managing GSH elevation and hypoxia to overcome resistance of cancer therapies using functionalized nanocarriers

  2021cites this paper